Новые возможности лечения пациента с сахарным диабетом и сердечной недостаточностью. Обобщенный российский опыт
Аннотация
Ключевые слова
Об авторах
А. С. АметовРоссия
Е. В. Доскина
Россия
Список литературы
1. http://www.diabetesatlas.org/
2. Clark CM, Perry RC. Type 2 diabetes and macro-vascular disease: epidemiology and etiology. Am. Heart J., 1999, 138(5), Pt. 1: S330-S333.
3. Fchtenbusch M, Standl E, Otter W, Hummel M. Diabetes mellitus and heart failure. MMW. Fortschr. Med., 2007, 149(37): 41-44.
4. The CONSENSUS trial study group. Effect of enal-april on mortality in severe congestive heart failure. N Engl J Med., 1987, 316: 1429-1435.
5. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med., 1991, 325: 293302.
6. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med., 1991, 325: 303-310.
7. Packer M, Poole-Wilson PA, Armstrong PM et al. on behalf of the ATLAS Study Group. Comparative effects of low doses of the angiotensin converting enzyme inhibitor lisinopril on morbidity and mortality in chronic heart failure. Submitted, 1998.
8. From AM, Leibson CL, Bursi F et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am. J. Med., 2006, 119(7): 591-599.
9. Kamalesh M, Cleophas TJ. Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39,505 subjects. J. Card. Fail., 2009, 15(4): 305-309.
10. Masoudi F.A., Inzucchi S.E. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. Am. J. Cardiol., 2007, 99(4A): 113B-132B.
11. Vaur L, Gueret P, Lievre M et al. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. Diabetes Care, 2003, 26(3): 855-860.
12. Bertoni AG, Hundley WG, Massing MW et al. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care, 2004, 27(3): 699-703.
13. Yamory et al. Taurine and Cardiac study, 2006.
14. Мановицкая А.В. Метаболическая терапия у пациентов с метаболическим синдромом. Поликлиника, 2012, 2/1: 25-28.
15. Manovitskaya A.V. Metabolic therapy in patients with metabolic syndrome. Poliklinika, 2012, 2/1: 25-28.
Для цитирования:
Аметов А.С., Доскина Е.В. Новые возможности лечения пациента с сахарным диабетом и сердечной недостаточностью. Обобщенный российский опыт. Медицинский Совет. 2016;(3):58-65. https://doi.org/10.21518/2079-701X-2016-3-58-65
For citation:
Ametov А.S., Doskina E.V. New options in the treatment of patients with diabetes and heart failure. Generalized Russian experience. Meditsinskiy sovet = Medical Council. 2016;(3):58-65. (In Russ.) https://doi.org/10.21518/2079-701X-2016-3-58-65